跳至主要内容
临床试验/NCT02344082
NCT02344082已完成不适用

Pharmacists Provide Telemedicine in Addition to Clinic Visits to Improve Diabetes Management

Johns Hopkins University0 个研究点目标入组 30 人开始时间: 2015年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
30
主要终点
Change in hemoglobin A1c

研究概览

简要总结

This prospective study will include both an intervention and control arm. The control arm will receive face-to-face pharmacy clinic visits per standard of care. The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up. Patients with a hemoglobin A1c in the last 3 months greater than 9% will be eligible. Eligible patients must have a primary care physician at Johns Hopkins Outpatient Center (JHOC) or East Baltimore Medical Center (EBMC).

Purpose: To compare the change in hemoglobin A1c over the 3 month study period in the intervention group in which patients participate in telemedicine, to a control group in which they do not

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with a primary care provider at JHOC or EMBC
  • Patients have seen primary care provider within last 6 months
  • Patients with hemoglobin A1c greater than 9%

排除标准

  • Patients <18 years of age
  • Patients with previously established care with JHH ambulatory care pharmacist
  • Patients with communication barriers who do not have a caregiver
  • Patients with new diagnosis of diabetes
  • Patients who are pregnant or planning to become pregnant during the time of the study
  • Patients followed by Endocrinology or Diabetes Center

研究组 & 干预措施

Standard of Care

No Intervention

The control arm will receive face-to-face pharmacy clinic visits per usual care.

Intervention Arm

Active Comparator

The intervention arm will receive pharmacy clinic visits plus additional telephone follow-up.

干预措施: Telemedicine (Other)

结局指标

主要结局

Change in hemoglobin A1c

时间窗: 3 months

A1c at 3 months - A1c at Baseline

次要结局

  • Pharmacist interventions (Number of pharmacist interventions (lifestyle or medication changes) made)(3 months)
  • Telemedicine Adherence (Percent of telephone encounters completed in intervention arm)(3 months)
  • Patient satisfaction (Based on survey results)(3 months)
  • Patient adherence to office visits (# visits attended/# of visits scheduled)(3 months)
  • Telemedicine in Usual Care (Percent of patients who receive telephone call under usual care)(3 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验